載入中
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
前收盤價
US$1.53
+US$0.31 · +25.41%
盤中時間採用ET。市場資料可能有所延遲。
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
日內區間
目前US$1.53
52週區間
目前US$1.53
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
強力賣出
估值
18
估值過高
情緒
33
看跌
風險
88
極高風險
動能
21
動能減弱
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
日內區間
目前US$1.53
52週區間
目前US$1.53
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 243.6萬 USD | 305.8萬 USD | 108.2萬 USD | — | — |
| 銷貨成本 | 128.3萬 USD | 145.8萬 USD | 59.4萬 USD | — | — |
| 毛利 | 115.3萬 USD | 160萬 USD | 48.8萬 USD | — | — |
| 研究與開發 | 5375.9萬 USD | 5964.1萬 USD | 6702.5萬 USD | 7206.2萬 USD | 4657.5萬 USD |
| 銷售、一般及管理費用 | 4475.4萬 USD | 5053.5萬 USD | 4463.4萬 USD | 4229.6萬 USD | 5033.3萬 USD |
| 營業費用 | 9851.3萬 USD | 1.1億 USD | 1.12億 USD | 1.24億 USD | 9690.8萬 USD |
| 利息收入 | 896.4萬 USD | — | — | — | — |
| 利息支出 | — | — | — | — | 5000 USD |
| 折舊和攤銷 | 445.4萬 USD | 460萬 USD | 415.6萬 USD | 258.4萬 USD | 104.1萬 USD |
| 營業利益 | −9736萬 USD | −1.09億 USD | −1.11億 USD | −1.24億 USD | −9690.8萬 USD |
| 淨利 | −1.01億 USD | −1.01億 USD | −9596萬 USD | −1.32億 USD | −9498.9萬 USD |
公司資料更新於 2026年10月11日。
報告持有此股票曝險的交易所交易基金。
ARK Genomic Revolution ETFARKG848.32萬0.41%15.57億 USD0.75%US$51.30+4.08%
Vanguard Morningstar Total Stock Market ETFVTI410.06萬0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Biotechnology ETFIBB160.36萬0.02%108.2億 USD0.44%US$206.49+3.00%
Vanguard Extended Market ETFVXF158.74萬0.00%954億 USD0.05%US$235+0.80%
Invesco RAFI US 1500 Small-Mid ETFPRFZ70.64萬0.03%26.7億 USD0.36%US$53.16+0.64%
iShares Core S&P Total U.S. Stock Market ETFITOT53.11萬0.00%980.88億 USD0.03%US$169.66+0.64%
Vanguard Health Care ETFVHT38.54萬0.00%220億 USD0.09%US$319.01+1.64%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM30萬0.26%1.17億 USD0.73%US$15.9402+0.25%ARK Genomic Revolution ETFARKGVanguard Morningstar Total Stock Market ETFVTIiShares Biotechnology ETFIBBVanguard Extended Market ETFVXFInvesco RAFI US 1500 Small-Mid ETFPRFZiShares Core S&P Total U.S. Stock Market ETFITOTVanguard Health Care ETFVHTEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
